Neurobiological Technologies News
Most Popular Neurobiological Technologies Story
Neurobiological to consider sale, liquidation
A badly crippled Neurobiological Technologies has brought a financial adviser on board to review a possible sale of the company or its major assets. And if that doesn't work out, the CEO raised the... Read more...
Latest Headlines
- October 28, 2009
- September 1, 2009
- March 26, 2009
- February 4, 2009
- January 13, 2009
- December 17, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
